Cover Image

Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer

Johann de Bono, Liji Shen, Oliver Sartor
  • Johann de Bono
    Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom |
  • Liji Shen
    Sanofi, Bridgewater, NJ, United States
  • Oliver Sartor
    Tulane University Medical School, New Orleans, LA, United States


Not available.


TROPIC; Cabazitaxel; Mitoxantrone

Full Text:

Submitted: 2016-01-25 17:35:55
Published: 2016-03-31 00:00:00
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Copyright (c) 2016 Johann de Bono, Liji Shen, Oliver Sartor

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© PAGEPress 2008-2018     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185     •     Privacy